Yemisi Oluwatosin

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Angiotensin Converting Enzyme

Mesenchymal Stem Cells

Chronic Kidney Disease

Top Venues

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen R Ash, Daniel Batlle, Jessica Kendrick, Yemisi Oluwatosin, Laura Kooienga, James M Eudicone, Anna-Karin Sundin, Emily Guerrieri, Linda F Fried
Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized Study. Kidney360 5 (6) (2024)
Stephen R Ash, Daniel Batlle, Jessica Kendrick, Yemisi Oluwatosin, Laura Kooienga, James M Eudicone, Anna-Karin Sundin, Emily Guerrieri, Linda F Fried
Sodium Zirconium Cyclosilicate in Chronic Kidney Disease, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized Study. Kidney360 (2024)
Stephen R Ash, Daniel Batlle, Jessica Kendrick, Yemisi Oluwatosin, Laura Kooienga, James M Eudicone, Anna-Karin Sundin, Emily Guerrieri, Linda F Fried
Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized Study. Kidney360 5 (6) (2024)
Stephen R Ash, Daniel Batlle, Jessica Kendrick, Yemisi Oluwatosin, Laura Kooienga, James M Eudicone, Anna-Karin Sundin, Emily Guerrieri, Linda F Fried
Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized Study. Kidney360 5 (6) (2024)
Stephen R Ash, Daniel Batlle, Jessica Kendrick, Yemisi Oluwatosin, Laura Kooienga, James M Eudicone, Anna-Karin Sundin, Emily Guerrieri, Linda F Fried
Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized Study. Kidney360 5 (6) (2024)
Stephen R Ash, Daniel Batlle, Jessica Kendrick, Yemisi Oluwatosin, Laura Kooienga, James M Eudicone, Anna-Karin Sundin, Emily Guerrieri, Linda F Fried
Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized Study. Kidney360 5 (6) (2024)
Jamie P Dwyer, Abiy Agiro, Pooja Desai, Yemisi Oluwatosin
Impact of Sodium Zirconium Cyclosilicate Plus Renin-Angiotensin-Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study. Advances in therapy (2023)